(WHDH) — CVS Pharmacy has suspended its sale of all Zantac and CVS Health ranitidine products after the Food and Drug Administration found low levels of a cancer-linked impurity in the common heartburn drugs.
The FDA recently found that ranitidine products may contain a low level of nitrosodimethylamine (NDMA), which is a probable human carcinogen.
The administration is continuing to evaluate whether low levels of NDMA in ranitidine pose a risk to patients.
The products have not been recalled but customers who purchased them can return them to CVS for a refund.
(Copyright (c) 2025 Sunbeam Television. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)